The EU Warns Kids About This Dye. India Doesn't Even Label It.

A recent study found that a significant share of Indian processed foods contain Yellow 5 (Tartrazine), a synthetic dye used to enhance colour in everything from beverages to snacks. It's important to be precise about its legal status from the outset: Tartrazine is legally permitted in India — this isn't a banned or illegal ingredient — but the way it's regulated differs meaningfully between India and other major markets, and that difference is worth understanding rather than a blanket "cancer risk" framing.

FSSAI permits Tartrazine (INS 102) in food at a maximum usage limit of approximately 200 parts per million (ppm), depending on the food category. India is one of eight countries that FSSAI's own regulatory framework permits to use all eight synthetic colours it authorises: Tartrazine, Carmoisine, Sunset Yellow FCF, Brilliant Blue FCF, Ponceau 4R, Allura Red, Erythrosine, and Indigo Carmine. By contrast, the EU requires a mandatory warning label — "may have an adverse effect on activity and attention in children" — on any product containing Tartrazine and five related dyes (the "Southampton Six"), following the 2007 Southampton study. The US permits Tartrazine (as FD&C Yellow No. 5) with a labelling requirement to name it specifically (unlike some other dyes that can be grouped under "artificial colours"), but no hyperactivity warning. India requires neither a specific hyperactivity warning nor mandatory individual dye naming beyond standard INS-code declaration.

Tartrazine is most commonly found in: yellow and green-tinted carbonated and non-carbonated beverages, custard powders, yellow-coloured candies and boiled sweets, some namkeen and snack seasonings, and flavoured dairy products like certain ice creams and yogurt drinks. Checking for "Tartrazine" or "INS 102" (or "E102") on the ingredient list is the direct way to identify it, since front-of-pack marketing rarely mentions specific colour additives by name.

The strongest, most consistently cited evidence on Tartrazine relates to behaviour, not cancer specifically: the 2007 Southampton study (published in The Lancet) found that mixtures of artificial food colours, including Tartrazine, increased hyperactivity in children in a double-blind trial — this is the basis for the EU's warning label requirement. On cancer risk specifically, the evidence is less settled than some consumer content suggests; Tartrazine is not currently classified by IARC as a carcinogen, and claims to that effect should be treated cautiously. Tartrazine is, however, a documented allergen — it can trigger allergic and asthmatic reactions in a subset of sensitive individuals, particularly those with aspirin sensitivity, which is a separate and well-established concern from the cancer question.

Children are the group with the strongest documented evidence of harm, via the hyperactivity/attention link established in the Southampton study — which is exactly why the EU's warning label targets children's attention and activity specifically. Individuals with known sensitivity to Tartrazine or aspirin-sensitive asthma should also be cautious, given the documented allergic-reaction risk. Pregnant women and breastfeeding mothers may reasonably choose to minimise exposure to synthetic dyes generally as a precaution, though the strongest specific evidence relates to childhood behaviour and allergic sensitivity rather than pregnancy outcomes.

The 2007 Southampton study, led by researchers at the University of Southampton and published in The Lancet, tested mixtures of artificial food colours (including Tartrazine) combined with the preservative sodium benzoate in two groups of children — 3-year-olds and 8/9-year-olds — using a randomised, double-blind, placebo-controlled crossover design, considered a strong study design for this kind of question. The study found a statistically significant increase in hyperactive behaviour in both age groups when consuming the colour-and-preservative mixtures compared to placebo, as rated by parents and, for the older group, independent observers. It's worth noting the study tested combinations of colours plus sodium benzoate together rather than isolating Tartrazine's individual effect, meaning the EU's resulting warning label applies broadly to the tested dye group rather than reflecting Tartrazine-specific isolated research — a nuance that doesn't undermine the finding's regulatory relevance but is worth knowing for precision.

Tartrazine's cancer-risk reputation in some consumer content appears to trace back to a confusion with other synthetic dyes that have faced more serious carcinogenicity scrutiny (such as some banned coal-tar dyes covered elsewhere in this site's food safety coverage), rather than to Tartrazine-specific carcinogenicity findings. IARC, the WHO's cancer research arm responsible for authoritative carcinogen classifications, has not classified Tartrazine as a carcinogen, and JECFA's safety re-evaluations have consistently maintained its permitted status with a defined Acceptable Daily Intake rather than flagging cancer risk as a basis for restriction. This is a useful example of how a genuine, well-documented concern (hyperactivity in children) can get conflated with a separate, less-supported claim (cancer) in less careful coverage of the same additive — worth untangling since the two claims carry very different levels of evidentiary support.

Tartrazine's documented allergic and asthmatic reaction risk is specifically elevated in people with aspirin sensitivity (aspirin-exacerbated respiratory disease), a connection that traces to a shared biochemical pathway rather than coincidence — both aspirin and Tartrazine can trigger reactions through effects on the same inflammatory prostaglandin pathway in sensitive individuals. For someone who already knows they react to aspirin or NSAIDs, this is a genuinely useful, actionable piece of information: checking labels for Tartrazine specifically is a reasonable precaution given this documented cross-sensitivity, distinct from the general population where this specific risk doesn't apply. For the broader population without known aspirin sensitivity, Tartrazine allergic reactions are considerably rarer, though not impossible.

Given the evidence covered throughout this guide, a proportionate response looks different depending on the household: for families with young children, treating the EU's hyperactivity warning as relevant guidance even without an equivalent Indian label — checking for Tartrazine specifically in children's snacks, drinks, and candy, and favouring naturally coloured or uncoloured alternatives where available — is a reasonable, evidence-aligned precaution. For anyone with known aspirin or NSAID sensitivity, the same label-checking habit is directly relevant to a documented personal risk. For the general adult population without either factor, Tartrazine at FSSAI-permitted concentrations doesn't carry strong evidence of harm beyond these specific groups, making moderate, non-alarmist awareness — rather than strict avoidance — a reasonable default.

Tartrazine's regulatory story illustrates a broader pattern relevant across several additives covered on this site: India frequently permits the same substances at similar concentrations as the EU and US, but without matching those markets' more specific disclosure or warning requirements — meaning the underlying safety assessment is often comparable, but the information available to an Indian shopper at the point of purchase is meaningfully less detailed. This gap is part of why FSSAI's ongoing front-of-pack labelling reforms, covered in a dedicated piece on this site, matter beyond their headline sugar-salt-fat focus — a more assertive labelling regime could plausibly extend to child-specific behavioural warnings for synthetic dyes as well, following the EU's model, though no such specific proposal has been part of the current FOP labelling debate as of this writing.

AaharIQ's food scanner app can help you identify Tartrazine and other synthetic colours in Indian processed foods. Simply scan the label of a product, and AaharIQ's AI-powered algorithm will detect the presence of Tartrazine and flag it against your health profile — particularly useful if you're managing a child's diet or have a known sensitivity. Get started with AaharIQ today and take control of your food choices — download the app for free at aahariq.com.

For anyone wanting to reduce Tartrazine exposure, natural yellow colourants exist and are increasingly used by brands positioning around "clean label" formulations: turmeric (curcumin) produces a similar yellow hue and is already a staple Indian kitchen ingredient with an established safety record at food-use concentrations; annatto, derived from achiote seeds, produces a yellow-orange shade used in some international products though less common in Indian formulations; and beta-carotene, the same compound giving carrots their colour, is used as a natural yellow-orange colourant in some fortified and premium products. None of these deliver the exact same vivid, consistent shade synthetic Tartrazine achieves, which is part of why manufacturers competing on visual brand consistency have been slower to reformulate away from it — but for a household cooking or shopping with an eye toward reducing synthetic dye exposure specifically, recognising these natural alternatives on an ingredient list is a useful positive signal to look for.

Does Tartrazine cause cancer? Current evidence doesn't support this — IARC has not classified it as a carcinogen, and this claim likely stems from confusion with other, more seriously scrutinised dyes rather than Tartrazine-specific research. Should I avoid it if my child doesn't seem hyperactive? The Southampton study found effects across the tested groups generally, not only in children with pre-existing hyperactivity, so the absence of obvious current symptoms doesn't rule out a subtle effect — moderate caution remains reasonable regardless. Is Tartrazine worse than other synthetic dyes? Not necessarily — several other permitted synthetic dyes share similar hyperactivity evidence from the same Southampton study and carry comparable allergy-risk profiles; Tartrazine isn't uniquely concerning within its category. Why does the US require naming it specifically but not a warning label? US labelling law has historically focused on ingredient transparency and specific allergen disclosure rather than behavioural-effect warnings, a different regulatory philosophy than the EU's more precautionary approach to this particular evidence base.